FDMT Earnings

Quarterly EPS
$-0.63
Q2 2024
$-0.79
Q3 2024
$-0.89
Q4 2024
$-0.86
Q1 2025
$-0.98
Q2 2025
$-1.01
Q3 2025
$0.30
Q4 2025
$-1.01
Q1 2026
Latest Revenue3.0M
Latest Net Income-68760000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q1 2026-$1.013.0M-68760000+21,664.3%-17.4%
Q4 2025$0.3085.1M19.4M+8,508,900.0%+133.7%
Q3 2025-$1.0190.0K-56876000+2,900.0%-27.8%
Q2 2025-$0.9815.0K-54658000+200.0%-55.6%
Q1 2025-$0.8614.0K-47972000-50.0%-30.3%
Q4 2024-$0.891.0K-49671000
Q3 2024-$0.793.0K-43843000-100.0%-229.2%
Q2 2024-$0.635.0K-34953000-97.9%+18.2%
Q1 2024-$0.6628.0K-32401000
Q4 2023
Q3 2023-$0.2420.2M-10256000
Q2 2023-$0.77239.0K-29616000
4D Molecular Therapeutics (FDMT) — Earnings